AFP and Italy’s Fort Bard renew their partnership with the launch of a second exhibition

Following the success of their first collaboration, AFP and Fort Bard have unveiled their latest exhibition, "Contrasts. Stories from a World on Edge," which will be on display until 20 July, 2025.

Following the success of their first collaboration, AFP and Fort Bard have unveiled their latest exhibition, "Contrasts. Stories from a World on Edge," which will be on display until 20 July, 2025.

AFP’s 2022 results: 5% growth in commercial revenues, new tensions on costs

At its meeting on 20 April 2023, AFP's Board of Directors approved the accounts for the 2022 financial year, which confirm the Agency's continued financial recovery.

At its meeting on 20 April 2023, AFP's Board of Directors approved the accounts for the 2022 financial year, which confirm the Agency's continued financial recovery.
Anglais

Turkey: AFP demands the immediate release of its photojournalist Yasin Akgül

AFP strongly condemns the detention of its journalist and photographer Yasin Akgül and calls for his immediate release. This is a serious attack on the freedom of the media.

AFP strongly condemns the detention of its journalist and photographer Yasin Akgül and calls for his immediate release. This is a serious attack on the freedom of the media.
Anglais

Ukrainian news agency trains in fact-checking with AFP and APA

After training with journalists from Agence France-Presse and the Austrian news agency APA, Ukraine’s largest news agency Ukrinform has started writing its own fact-check articles in an effort to confront a wave of war-related disinformation.

After training with journalists from Agence France-Presse and the Austrian news agency APA, Ukraine’s largest news agency Ukrinform has started writing its own fact-check articles in an effort to confront a wave of war-related disinformation.
Anglais
12/02/2025 11:00
AI Takes Center Stage as the Major Threat to Cybersecurity in 2026

Experian® today released its 2026 Data Breach Industry Forecast, offering a look at the evolving cyber threat landscape. The predictions address how the coming year could usher in a new wave of sophisticated attacks driven by artificial intelligence along with other threats and vulnerabilities including quantum computing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202474758/en/Experian's 2026 Data Breach Industry Forecast Now ...

10/25/2025 23:55
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis

Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs). These data will be presented during the Systemic and New Therapies for Atopic Dermatitis session on Sunday, October 26 at 10:55 a.m. AEDT (Saturday, October 25 at 7...

10/30/2025 01:00
Yokogawa to Deliver Integrated Control Systems for Urban Infrastructure in Green Riyadh Project

Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary, Yokogawa Saudi Arabia, has been awarded a contract by the Royal Commission for Riyadh City to provide the necessary systems and services for the main command and control center of the Green Riyadh project*. Led by the Government of Saudi Arabia, this national initiative is a key element of Saudi Vision 2030. Its objective is to transform Riyadh into one of the world’s most livable cities through urban greening, enabling ...

AFP awarded at NPPA’s 2023 "Best Of Photojournalism Competition"

The NPPA (National Press Photographers Association) Awards have honoured AFP photographer Luis Tato with three prizes in the Science, Science Story and Politics Story categories.

The NPPA (National Press Photographers Association) Awards have honoured AFP photographer Luis Tato with three prizes in the Science, Science Story and Politics Story categories.
AFP Sports

Discover
12/02/2025 11:32
Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the first healthy volunteer in the Phase 1 clinical study of EGL-003, an IL‑2⍺-biased mutein designed to selectively activate Tregs while limiting effector T cell stimulation, as a potential treatment for atopic dermatitis. The open-label, multi-center Phase 1 trial begins with a single ascending dose p...

Subscribe to